Dae-young D. Kim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Management of immune thrombocytopenia: 2022 update of Korean experts recommendations.
Journal: Blood research
Published: February 18, 2022
Patient-specific molecular response dynamics can predict the possibility of relapse during the second treatment-free remission attempt in chronic myelogenous leukemia.
Journal: Neoplasia (New York, N.Y.)
Published: February 07, 2022
Ultra-deep sequencing mutation analysis of the BCR/ABL1 kinase domain in newly diagnosed chronic myeloid leukemia patients.
Journal: Leukemia research
Published: February 28, 2021
Hymenobacter lutimineralis sp. nov., belonging to the family Hymenobacteraceae, isolated from zeolite.
Journal: Antonie van Leeuwenhoek
Published: December 10, 2019
Use of Droplet Digital Polymerase Chain Reaction for Detecting Minimal Residual Disease: A Prospective Multi-Institutional Study.
Journal: In vivo (Athens, Greece)
Published: July 10, 2019
Blast Percentage of Bone Marrow Aspirate on Day 14 of Induction Chemotherapy Predicts Adult Acute Lymphoblastic Leukemia Treatment Outcomes.
Journal: Acta haematologica
Published: November 27, 2017
A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKorea.
Journal: Cancer medicine
Published: November 06, 2017
Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 21, 2017
Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 12, 2017
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: March 01, 2017
Last Updated: 09/26/2026